The objective of this study was to measure the efficacy of biphasic positive airway pressure (BIPAP) and synchronized intermittent mandatory ventilation (SIMV) with alveolar recruitment maneuvers (ARMs) in patients with acute lung injury (ALI) and concomitant pneumothorax. Seventy-four patients with ALI and concomitant pneumothorax secondary to blunt thoracic injury were studied. All patients fulfilled criteria for the first stage of acute respiratory distress syndrome, which consisted of acute onset dyspnea, isolated rales, an extravascular lung water index >7 mL/kg, and an oxygenation index <300 mm Hg in the absence of left-ventricular dysfunction. After evacuation of the pneumothorax, ARMs were performed using BIPAP or SIMV 3 to 5 times a day with a peak pressure of 33.4 ± 0.2 cm H(2)O and a positive end-expiratory pressure of 16.1 ± 0.2 cm H(2)O. The use of BIPAP in patients with ALI and concomitant pneumothorax reduced the time to resolution of the air leak allowing application of earlier ARMs. ARMs with peak pressures of 35 to 40 cm H(2)O effectively improved oxygenation and biomechanical properties of the lungs and did not cause pneumothorax relapse. In conclusion, BIPAP allowed for spontaneous ventilation during the breathing cycle and limited P (peak). Its use was associated with more rapid sealing of air leaks with the ability to conduct earlier ARMs. The use of BIPAP compared with SIMV improved outcome in the presence of complex thoracic trauma.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.